ZymeLink™ Conjugation Platform + Cytotoxins

The ZymeLink™ conjugation platform and proprietary cytotoxins are a modular suite of site-specific conjugation technologies, customizable linkers, and proprietary cytotoxic payloads designed for the targeted delivery of therapeutics with optimal efficacy and safety profiles. Together, the ZymeLink™ conjugation platform and proprietary cytotoxins are compatible with traditional monoclonal antibodies and with the Azymetric™ (bispecific) and AlbuCORE™ (multispecific) platforms for the development of next-generation biotherapeutics.

Display page(s):